DENT First Site In the Country to Administer New ALS Treatment
Posted on: 08/15/2017
On Friday, August 11, DENT became the first site in the United States to administer the new FDA approved amyotrophic lateral sclerosis (ALS) specific treatment, Radicava. Radicava is the first ALS specific treatment in 22 years and gives new hope to ALS patients. We are excited to continue being on the forefront of innovative treatments in WNY.
Click here to learn more about this groundbreaking new treatment. https://www.mt-pharma-america.com/wp-content/uploads/2017/08/RADICAVA-Availability-Press-Release.pdfBack to Article List